What are the major opportunities in the Pleural Diseases market? What are the strategies for the Pleural Diseases market?

For detailed insights on the major opportunities and strategies in the Pleural Diseases market, Read More

How does the Pleural Diseases market relate to the overall economy and other similar markets?

For detailed insights on Pleural Diseases's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Pleural Diseases market growth? SWOT analysis of the Pleural Diseases market.

For detailed insights on the key dynamics influencing the Pleural Diseases market growth and SWOT analysis of the Pleural Diseases industry, Read More

Pleural Diseases Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Pleural Diseases Market Report 2026

Name: Pleural Diseases Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Disease Type (Pleurisy, Pleural Effusion, Pneumothelioma, Mesothelioma, Other Disease Types ), By Treatment Modalities (Medications, Thoracentesis And Pleurodesis, Minimally Invasive Interventions, Surgical Interventions ), By Diagnostic Tools (Imaging Techniques, Molecular Diagnostics, Thoracoscopy, Pleuroscopy ), By End User (Hospitals And Clinics, Diagnostic Centers, Research And Academic Institutions) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Purchase This Report Download Sample PDF

Item added to cart!

Pleural Diseases Market Overview

• Pleural Diseases market size has reached to $5.21 billion in 2025

• Expected to grow to $7.35 billion in 2030 at a compound annual growth rate (CAGR) of 7.1%

• Growth Driver: Rising Prevalence Of Infectious Diseases Driving The Growth Of The Market Due To Increasing Risk Of Infections Leading To Pleural Complications

• Market Trend: Advancing Treatment Accessibility With Ready-To-Use Injectable Innovations

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Pleural Diseases Market?

Pleural diseases refer to a group of conditions that affect the pleura, which is the double-layered membrane surrounding the lungs. These diseases can involve inflammation, infection, or other pathological pleural changes. Pleural diseases cause chest pain, shortness of breath, coughing, and difficulty breathing and are often diagnosed with imaging tests such as chest X-rays or CT scans.

The main disease types of pleural diseases are pleurisy, pleural effusion, pneumothorax, mesothelioma, and others. Pleurisy, characterized by inflammation of the pleura, causes sharp chest pain and is linked to infections or autoimmune disorders. Treatment options encompass medications, thoracentesis, pleurodesis, minimally invasive procedures, and surgical interventions. Diagnostics involve imaging techniques, molecular diagnostics, thoracoscopy, and pleuroscopy. These services are utilized in hospitals, clinics, diagnostic centers, and research or academic institutions.

Pleural Diseases Market Global Report 2026 Market Report bar graph

What Is The Pleural Diseases Market Size and Share 2026?

The pleural diseases market size has grown strongly in recent years. It will grow from $5.21 billion in 2025 to $5.6 billion in 2026 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to increasing incidence of respiratory diseases, rising prevalence of pleural effusion and mesothelioma, wider availability of diagnostic imaging, expansion of pulmonology services, growth in hospital-based respiratory care.

What Is The Pleural Diseases Market Growth Forecast?

The pleural diseases market size is expected to see strong growth in the next few years. It will grow to $7.35 billion in 2030 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to increasing investments in early cancer detection, rising demand for minimally invasive diagnostics, expansion of precision medicine approaches, growing focus on outpatient respiratory care, advancements in pleural disease therapeutics. Major trends in the forecast period include increasing adoption of advanced imaging diagnostics, rising use of minimally invasive pleural interventions, growing integration of molecular diagnostic tools, expansion of early disease detection programs, enhanced focus on personalized treatment approaches.

Book your 30 minutes free consultation with our research experts

Global Pleural Diseases Market Segmentation

1) By Disease Type: Pleurisy, Pleural Effusion, Pneumothelioma, Mesothelioma, Other Disease Types

2) By Treatment Modalities: Medications, Thoracentesis And Pleurodesis, Minimally Invasive Interventions, Surgical Interventions

3) By Diagnostic Tools: Imaging Techniques, Molecular Diagnostics, Thoracoscopy, Pleuroscopy

4) By End User: Hospitals And Clinics, Diagnostic Centers, Research And Academic Institutions

Subsegments:

1) By Pleurisy: Acute Pleurisy, Chronic Pleurisy, Infectious Pleurisy, Non-infectious Pleurisy

2) By Pleural Effusion: Transudative Pleural Effusion, Exudative Pleural Effusion, Malignant Pleural Effusion, Parapneumonic Pleural Effusion, Hemothorax, Chylothorax

3) By Pneumothelioma: Primary Pneumothelioma, Secondary Pneumothelioma (Metastatic), Localized Pneumothelioma, Diffuse Pneumothelioma

4) By Mesothelioma: Pleural Mesothelioma, Benign Pleural Tumors, Pleural Thickening Disorders, Pleural Plaques

5) By Other Disease Types: Empyema, Fibrothorax, Pneumothorax, Lung Cancer, Tuberculosis-Related Pleural Disease, Sarcoidosis

What Is The Driver Of The Pleural Diseases Market?

The increasing prevalence of infectious diseases are expected to drive the growth of the pleural diseases market going forward. Infectious diseases are illnesses caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites. Environmental changes to human behavior and advancements in global travel influence the increasing prevalence of infectious diseases. Infectious diseases such as bacterial pneumonia, tuberculosis, or viral infections can cause pleural disease by triggering inflammation, infection, or fluid accumulation in the pleural cavity. For instance, in January 2023, according to the National Library of Medicine, a US-based medical library for research and information, infectious diseases account for over 52 million deaths annually, placing half of the global population at risk. Further, each year, approximately 14 million children under the age of five die, with 70% of these deaths attributed to diseases that could be prevented through vaccination. Therefore, the increasing prevalence of infectious diseases drives the growth of the pleural diseases industry.

Key Players In The Global Pleural Diseases Market

Major companies operating in the pleural diseases market are Pfizer Inc., Merck & Co. Inc., Bristol Myers Squibb Company, GSK plc, Astrazeneca plc, Koninklijke Philips N.V., Becton Dickinson and Company, Boehringer Ingelheim International GmbH, Sanofi SA, Penn Medicine, Henry Ford Health, Dragerwerk AG, Emory Healthcare, Boston Medical Center, Cook Medical, WakeMed, Weill Cornell Medicine, Fox Chase Cancer Center, B. Braun SE, Bicakcilar, Redax S.p.a, Rocket Medical

Global Pleural Diseases Market Trends and Insights

Major companies operating in the pleural diseases market are focusing on developing innovative treatment options, such as developing ready-to-use injectable treatments, to improve convenience, reduce preparation time, and minimize dosing errors. Ready-to-use injectable treatments are pre-formulated, pre-diluted medications that require no reconstitution or mixing before administration, ensuring accuracy, convenience, and reduced preparation time. For instance, in April 2024, Amneal Pharmaceuticals, a US-based pharmaceutical company, launched PEMRYDI RTU, the first ready-to-use version of pemetrexed for injection. This helps people with pleural diseases by providing a convenient, ready-to-use treatment that eliminates the need for reconstitution or dilution, reduces preparation time, minimizes the risk of dosing errors, and improves access to effective therapy for conditions like malignant pleural mesothelioma.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Pleural Diseases Market?

In October 2023, Aileron Therapeutics Inc., a US-based biopharmaceutical company, acquired Lung Therapeutics Inc. for an undisclosed amount. This acquisition strengthens the pipeline by integrating LTI-03 for idiopathic pulmonary fibrosis (IPF) and LTI-01 for loculated pleural effusions (LPEs), expanding the focus on orphan pulmonary and fibrosis diseases. Lung Therapeutics Inc. is a US-based biopharmaceutical company developing innovative peptide drugs targeting fibrosis and rare pulmonary conditions.

Regional Outlook

North America was the largest region in the pleural diseases market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Pleural Diseases Market?

The pleural diseases market consist of revenues earned by entities by providing services such as diagnostic, pleurodesis, respiratory therapy, rehabilitation, and biopsy procedures. The market value includes the value of related goods sold by the service provider or included within the service offering. The pleural diseases market also includes sales of antibiotics, chemotherapeutic agents, thoracentesis kits, chest tubes and drainage systems, and pleural biopsy needles. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Pleural Diseases Market Report 2026?

The pleural diseases market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the pleural diseases industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Pleural Diseases Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$5.6 billion
Revenue Forecast In 2035	$7.35 billion
Growth Rate	CAGR of 7.3% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Disease Type, Treatment Modalities, Diagnostic Tools, End User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Pfizer Inc., Merck & Co. Inc., Bristol Myers Squibb Company, GSK plc, Astrazeneca plc, Koninklijke Philips N.V., Becton Dickinson and Company, Boehringer Ingelheim International GmbH, Sanofi SA, Penn Medicine, Henry Ford Health, Dragerwerk AG, Emory Healthcare, Boston Medical Center, Cook Medical, WakeMed, Weill Cornell Medicine, Fox Chase Cancer Center, B. Braun SE, Bicakcilar, Redax S.p.a, Rocket Medical
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Pleural Diseases Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Pleural Diseases Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Pleural Diseases Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Pleural Diseases Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Increasing Adoption Of Advanced Imaging Diagnostics

4.2.2 Rising Use Of Minimally Invasive Pleural Interventions

4.2.3 Growing Integration Of Molecular Diagnostic Tools

4.2.4 Expansion Of Early Disease Detection Programs

4.2.5 Enhanced Focus On Personalized Treatment Approaches

5. Pleural Diseases Market Analysis Of End Use Industries

5.1 Hospitals And Clinics

5.2 Diagnostic Centers

5.3 Pulmonology Centers

5.4 Oncology Centers

5.5 Research And Academic Institutions

6. Pleural Diseases Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Pleural Diseases Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Pleural Diseases PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Pleural Diseases Market Size, Comparisons And Growth Rate Analysis

7.3. Global Pleural Diseases Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Pleural Diseases Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Pleural Diseases Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Pleural Diseases Market Segmentation

9.1. Global Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Pleurisy, Pleural Effusion, Pneumothelioma, Mesothelioma, Other Disease Types

9.2. Global Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Medications, Thoracentesis And Pleurodesis, Minimally Invasive Interventions, Surgical Interventions

9.3. Global Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Imaging Techniques, Molecular Diagnostics, Thoracoscopy, Pleuroscopy

9.4. Global Pleural Diseases Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals And Clinics, Diagnostic Centers, Research And Academic Institutions

9.5. Global Pleural Diseases Market, Sub-Segmentation Of Pleurisy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Acute Pleurisy, Chronic Pleurisy, Infectious Pleurisy, Non-infectious Pleurisy

9.6. Global Pleural Diseases Market, Sub-Segmentation Of Pleural Effusion, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Transudative Pleural Effusion, Exudative Pleural Effusion, Malignant Pleural Effusion, Parapneumonic Pleural Effusion, Hemothorax, Chylothorax

9.7. Global Pleural Diseases Market, Sub-Segmentation Of Pneumothelioma, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Primary Pneumothelioma, Secondary Pneumothelioma (Metastatic), Localized Pneumothelioma, Diffuse Pneumothelioma

9.8. Global Pleural Diseases Market, Sub-Segmentation Of Mesothelioma, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Pleural Mesothelioma, Benign Pleural Tumors, Pleural Thickening Disorders, Pleural Plaques

9.9. Global Pleural Diseases Market, Sub-Segmentation Of Other Disease Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Empyema, Fibrothorax, Pneumothorax, Lung Cancer, Tuberculosis-Related Pleural Disease, Sarcoidosis

10. Pleural Diseases Market Regional And Country Analysis

10.1. Global Pleural Diseases Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Pleural Diseases Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Pleural Diseases Market

11.1. Asia-Pacific Pleural Diseases Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Pleural Diseases Market, Segmentation By Disease Type, Segmentation By Treatment Modalities, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Pleural Diseases Market

12.1. China Pleural Diseases Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Pleural Diseases Market, Segmentation By Disease Type, Segmentation By Treatment Modalities, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Pleural Diseases Market

13.1. India Pleural Diseases Market, Segmentation By Disease Type, Segmentation By Treatment Modalities, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Pleural Diseases Market

14.1. Japan Pleural Diseases Market Overview

14.2. Japan Pleural Diseases Market, Segmentation By Disease Type, Segmentation By Treatment Modalities, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Pleural Diseases Market

15.1. Australia Pleural Diseases Market, Segmentation By Disease Type, Segmentation By Treatment Modalities, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Pleural Diseases Market

16.1. Indonesia Pleural Diseases Market, Segmentation By Disease Type, Segmentation By Treatment Modalities, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Pleural Diseases Market

17.1. South Korea Pleural Diseases Market Overview

17.2. South Korea Pleural Diseases Market, Segmentation By Disease Type, Segmentation By Treatment Modalities, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Pleural Diseases Market

18.1. Taiwan Pleural Diseases Market Overview

18.2. Taiwan Pleural Diseases Market, Segmentation By Disease Type, Segmentation By Treatment Modalities, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Pleural Diseases Market

19.1. South East Asia Pleural Diseases Market Overview

19.2. South East Asia Pleural Diseases Market, Segmentation By Disease Type, Segmentation By Treatment Modalities, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Pleural Diseases Market

20.1. Western Europe Pleural Diseases Market Overview

20.2. Western Europe Pleural Diseases Market, Segmentation By Disease Type, Segmentation By Treatment Modalities, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Pleural Diseases Market

21.1. UK Pleural Diseases Market, Segmentation By Disease Type, Segmentation By Treatment Modalities, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Pleural Diseases Market

22.1. Germany Pleural Diseases Market, Segmentation By Disease Type, Segmentation By Treatment Modalities, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Pleural Diseases Market

23.1. France Pleural Diseases Market, Segmentation By Disease Type, Segmentation By Treatment Modalities, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Pleural Diseases Market

24.1. Italy Pleural Diseases Market, Segmentation By Disease Type, Segmentation By Treatment Modalities, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Pleural Diseases Market

25.1. Spain Pleural Diseases Market, Segmentation By Disease Type, Segmentation By Treatment Modalities, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Pleural Diseases Market

26.1. Eastern Europe Pleural Diseases Market Overview

26.2. Eastern Europe Pleural Diseases Market, Segmentation By Disease Type, Segmentation By Treatment Modalities, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Pleural Diseases Market

27.1. Russia Pleural Diseases Market, Segmentation By Disease Type, Segmentation By Treatment Modalities, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Pleural Diseases Market

28.1. North America Pleural Diseases Market Overview

28.2. North America Pleural Diseases Market, Segmentation By Disease Type, Segmentation By Treatment Modalities, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Pleural Diseases Market

29.1. USA Pleural Diseases Market Overview

29.2. USA Pleural Diseases Market, Segmentation By Disease Type, Segmentation By Treatment Modalities, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Pleural Diseases Market

30.1. Canada Pleural Diseases Market Overview

30.2. Canada Pleural Diseases Market, Segmentation By Disease Type, Segmentation By Treatment Modalities, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Pleural Diseases Market

31.1. South America Pleural Diseases Market Overview

31.2. South America Pleural Diseases Market, Segmentation By Disease Type, Segmentation By Treatment Modalities, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Pleural Diseases Market

32.1. Brazil Pleural Diseases Market, Segmentation By Disease Type, Segmentation By Treatment Modalities, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Pleural Diseases Market

33.1. Middle East Pleural Diseases Market Overview

33.2. Middle East Pleural Diseases Market, Segmentation By Disease Type, Segmentation By Treatment Modalities, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Pleural Diseases Market

34.1. Africa Pleural Diseases Market Overview

34.2. Africa Pleural Diseases Market, Segmentation By Disease Type, Segmentation By Treatment Modalities, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Pleural Diseases Market Regulatory and Investment Landscape

36. Pleural Diseases Market Competitive Landscape And Company Profiles

36.1. Pleural Diseases Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Pleural Diseases Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Pleural Diseases Market Company Profiles

36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Bristol Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

36.3.4. GSK plc Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Astrazeneca plc Overview, Products and Services, Strategy and Financial Analysis

37. Pleural Diseases Market Other Major And Innovative Companies

Koninklijke Philips N.V., Becton Dickinson and Company, Boehringer Ingelheim International GmbH, Sanofi SA, Penn Medicine, Henry Ford Health, Dragerwerk AG, Emory Healthcare, Boston Medical Center, Cook Medical, WakeMed, Weill Cornell Medicine, Fox Chase Cancer Center, B. Braun SE, Bicakcilar

38. Global Pleural Diseases Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Pleural Diseases Market

40. Pleural Diseases Market High Potential Countries, Segments and Strategies

40.1 Pleural Diseases Market In 2030 - Countries Offering Most New Opportunities

40.2 Pleural Diseases Market In 2030 - Segments Offering Most New Opportunities

40.3 Pleural Diseases Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Pleural Diseases Market, Overview Of Key Products - Product Examples

Table 2: Global Pleural Diseases Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Pleural Diseases Market, Supply Chain Analysis

Table 4: Global Pleural Diseases Market, Major Raw Material Providers

Table 5: Global Pleural Diseases Market, Major Resource Providers

Table 6: Global Pleural Diseases Market, Major Manufacturers (Suppliers)

Table 7: Global Pleural Diseases Market, Major Distributors And Channel Partners

Table 8: Global Pleural Diseases Market, Key Technologies & Future Trends

Table 9: Global Pleural Diseases Market, Major Trends

Table 10: Global Pleural Diseases Market, Major End Users

Table 11: Global Pleural Diseases Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Pleural Diseases Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Pleural Diseases Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Pleural Diseases Market - TAM, US$ Billion, 2025

Table 15: Global Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Pleural Diseases Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Pleural Diseases Market, Sub-Segmentation Of Pleurisy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Pleural Diseases Market, Sub-Segmentation Of Pleural Effusion, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Pleural Diseases Market, Sub-Segmentation Of Pneumothelioma, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Pleural Diseases Market, Sub-Segmentation Of Mesothelioma, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Pleural Diseases Market, Sub-Segmentation Of Other Disease Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Global Pleural Diseases Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Global Pleural Diseases Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: Asia-Pacific, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: Asia-Pacific, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: China, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: China, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: India, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: India, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Japan, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Japan, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Australia, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Australia, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Indonesia, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: Indonesia, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: South Korea, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: South Korea, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: Taiwan, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: Taiwan, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: South East Asia, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: South East Asia, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: Western Europe, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: Western Europe, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: UK, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: UK, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Germany, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: Germany, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: France, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: France, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Italy, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Italy, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Spain, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Spain, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Eastern Europe, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Eastern Europe, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: Russia, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: Russia, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: North America, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: North America, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: USA, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: USA, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: Canada, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: Canada, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: South America, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: South America, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Brazil, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Brazil, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Middle East, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Middle East, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Africa, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 97: Africa, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 98: Global Pleural Diseases Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 99: Global Pleural Diseases Market - Company Scoring Matrix

Table 100: Pfizer Inc. Financial Performance

Table 101: Merck & Co. Inc. Financial Performance

Table 102: Bristol Myers Squibb Company Financial Performance

Table 103: GSK plc Financial Performance

Table 104: Astrazeneca plc Financial Performance

Table 105: Global Pleural Diseases Market, Competitive Benchmarking (In USD Billions)

Table 106: Global Pleural Diseases Market, Competitive Dashboard

Table 107: Global Pleural Diseases Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 108: Global, Pleural Diseases Market Size Gain ($ Billion), Segmentation By Disease Type, 2025 – 2030

Table 109: Global, Pleural Diseases Market Size Gain ($ Billion), Segmentation By Treatment Modalities, 2025 – 2030

Table 110: Global, Pleural Diseases Market Size Gain ($ Billion), Segmentation By Diagnostic Tools, 2025 – 2030

List Of Figures

Figure 1: Global Pleural Diseases Market, Overview Of Key Products - Product Examples

Figure 2: Global Pleural Diseases Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Pleural Diseases Market, Supply Chain Analysis

Figure 4: Global Pleural Diseases Market, Major Raw Material Providers

Figure 5: Global Pleural Diseases Market, Major Resource Providers

Figure 6: Global Pleural Diseases Market, Major Manufacturers (Suppliers)

Figure 7: Global Pleural Diseases Market, Major Distributors And Channel Partners

Figure 8: Global Pleural Diseases Market, Key Technologies & Future Trends

Figure 9: Global Pleural Diseases Market, Major Trends

Figure 10: Global Pleural Diseases Market, Major End Users

Figure 11: Global Pleural Diseases Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Pleural Diseases Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Pleural Diseases Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Pleural Diseases Market - TAM, US$ Billion, 2025

Figure 15: Global Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Pleural Diseases Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Pleural Diseases Market, Sub-Segmentation Of Pleurisy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Pleural Diseases Market, Sub-Segmentation Of Pleural Effusion, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Pleural Diseases Market, Sub-Segmentation Of Pneumothelioma, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Pleural Diseases Market, Sub-Segmentation Of Mesothelioma, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Pleural Diseases Market, Sub-Segmentation Of Other Disease Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Global Pleural Diseases Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Global Pleural Diseases Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: Asia-Pacific, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: Asia-Pacific, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: China, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: China, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: India, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: India, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Japan, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Japan, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Australia, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Australia, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Indonesia, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: Indonesia, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: South Korea, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: South Korea, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: Taiwan, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: Taiwan, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: South East Asia, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: South East Asia, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: Western Europe, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: Western Europe, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: UK, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: UK, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Germany, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: Germany, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: France, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: France, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Italy, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Italy, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Spain, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Spain, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Eastern Europe, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Eastern Europe, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: Russia, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: Russia, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: North America, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: North America, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: USA, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: USA, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: Canada, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: Canada, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: South America, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: South America, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Brazil, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Brazil, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Middle East, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Middle East, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Africa, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 97: Africa, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 98: Global Pleural Diseases Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 99: Global Pleural Diseases Market - Company Scoring Matrix

Figure 100: Pfizer Inc. Financial Performance

Figure 101: Merck & Co. Inc. Financial Performance

Figure 102: Bristol Myers Squibb Company Financial Performance

Figure 103: GSK plc Financial Performance

Figure 104: Astrazeneca plc Financial Performance

Figure 105: Global Pleural Diseases Market, Competitive Benchmarking (In USD Billions)

Figure 106: Global Pleural Diseases Market, Competitive Dashboard

Figure 107: Global Pleural Diseases Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 108: Global, Pleural Diseases Market Size Gain ($ Billion), Segmentation By Disease Type, 2025 – 2030

Figure 109: Global, Pleural Diseases Market Size Gain ($ Billion), Segmentation By Treatment Modalities, 2025 – 2030

Figure 110: Global, Pleural Diseases Market Size Gain ($ Billion), Segmentation By Diagnostic Tools, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Aortic Aneurysm Market Report 2026 - Global Outlook – By Type (Thoracic Aortic Aneurysm (TAA), Abdominal Aortic Aneurysm (AAA)), By Treatment (Open Surgical Repair (OSR), Endovascular Aneurysm Repair (EVAR)), By End User...

Embolization Coils Market Report 2026 - Global Outlook – By Type (Detachable Coil, Pushable Coil), By Material (Platinum, Platinum And Hydrogel, Platinum Tungsten Alloy), By Application (Neurology, Urology, Peripheral Va...

Interstitial Lung Disease Market Report 2026 - Global Outlook – By Drug Type (Oral Corticosteroids, Immune Suppressing, Anti-Fibrotic Medication, Other Drugs), By Disease Type (Interstitial Pneumonia, Idiopathic Pulmonar...

Peripheral Artery Disease Market Report 2026 - Global Outlook – By Type (Peripheral Angioplasty Balloons, Peripheral Stents, Peripheral Catheters, Inferior Vena Cava (IVC) Filters, Plaque Modification Devices, Hemodynami...

Cardiometabolic Diseases Market Report 2026 - Global Outlook – By Type (Chronic Or Congestive Heart Failure, Hypertension, Type 2 Diabetes, Obesity), By Treatment (ACE inhibitors, Diuretics, Glucophage), By Dosage (Table...

Black Lung Disease Market Report 2026 - Global Outlook – By Type (Simple Coal Worker’s Pneumoconiosis, Complicated Coal Worker’s Pneumoconiosis), By Treatment (Oxygen Therapy, Bronchodilators, Lung Transplant, Stem Cell ...

Pulmonary Embolism Market Report 2026 - Global Outlook – By Treatment (Medications, Mechanical Devices, Other Treatments), By Diagnosis (Chest X-Ray, Electrocardiogram (ECG), Magnetic Resonance Imaging (MRI), Computed To...

Frequently Asked Questions

How big is the Pleural Diseases Market?

The Pleural Diseases market was valued at $5.21 billion in 2025, increased to $5.6 billion in 2026, and is projected to reach $7.35 billion by 2030.

What is the Pleural Diseases market growth?

The global Pleural Diseases market is expected to grow at a CAGR of 7.1% from 2026 to 2035 to reach $7.35 billion by 2035.

Who are the key players in Pleural Diseases market?

Some Key Players in the Pleural Diseases market Include, Pfizer Inc., Merck & Co. Inc., Bristol Myers Squibb Company, GSK plc, Astrazeneca plc, Koninklijke Philips N.V., Becton Dickinson and Company, Boehringer Ingelheim International GmbH, Sanofi SA, Penn Medicine, Henry Ford Health, Dragerwerk AG, Emory Healthcare, Boston Medical Center, Cook Medical, WakeMed, Weill Cornell Medicine, Fox Chase Cancer Center, B. Braun SE, Bicakcilar, Redax S.p.a, Rocket Medical .

What is the anticipated growth trend for the Pleural Diseases market?

Major trend in this market includes: Advancing Treatment Accessibility With Ready-To-Use Injectable Innovations. For further insights on this market. request a sample here

Which region has the most growth potential in the Pleural Diseases market?

North America was the largest region in the pleural diseases market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pleural diseases market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.